Impact of Tat Genetic Variation on HIV-1 Disease
Author(s) -
Luna Li,
Satinder Dahiya,
Sandhya Kortagere,
Benjamas Aiamkitsumrit,
David Cunningham,
Vanessa Pirrone,
Michael R. nemacher,
Brian Wigdahl
Publication year - 2012
Publication title -
advances in virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.956
H-Index - 25
eISSN - 1687-8647
pISSN - 1687-8639
DOI - 10.1155/2012/123605
Subject(s) - transactivation , biology , long terminal repeat , gene , transcription (linguistics) , virology , gene expression , genetics , viral protein , regulation of gene expression , virus , linguistics , philosophy
The human immunodeficiency virus type 1 (HIV-1) promoter or long-terminal repeat (LTR) regulates viral gene expression by interacting with multiple viral and host factors. The viral transactivator protein Tat plays an important role in transcriptional activation of HIV-1 gene expression. Functional domains of Tat and its interaction with transactivation response element RNA and cellular transcription factors have been examined. Genetic variation within tat of different HIV-1 subtypes has been shown to affect the interaction of the viral transactivator with cellular and/or viral proteins, influencing the overall level of transcriptional activation as well as its action as a neurotoxic protein. Consequently, the genetic variability within tat may impact the molecular architecture of functional domains of the Tat protein that may impact HIV pathogenesis and disease. Tat as a therapeutic target for anti-HIV drugs has also been discussed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom